2025
EYRC Prizes @ 9th ENEA Workshop, Marseille, France (3-5 December 2025)
- BEST BASIC POSTER: Fabio Bioletto
- BEST CLINICAL POSTER: Alessandra Vicari
- BEST BASIC ORAL COMMUNICATION: Mattia Dalle Nogare
- BEST CLINICAL ORAL COMMUNICATION: Angelo Milioto
2024
EYRC Prizes @ 21st ENEA Congress, Seville – Spain, 11-13 September 2024
- BEST BASIC POSTER: Federica Mangili
β-Arrestin 2 protein expression correlated with non-functioning pituitary tumors (NF-PitNETs) in vitro responsiveness to dopamine agonists - BEST CLINICAL POSTER: Loren Van der Hoeven
Cell lineage specific differences in clinical behavior of clinically non-functioning pituitary adenomas – A systematic review and meta-analysis - BEST BASIC ORAL COMMUNICATION: Athina Mavropoulou
Reduction of oxytocin-expressing neurons and aquaporin 4-expressing astrocytes in hypothalamus of hypercortisolaemic patients - BEST CLINICAL ORAL COMMUNICATION: Cihan Atila
Validation of baseline laboratory levels and a novel probability score in the diagnosis of patients with suspected Arginine Vasopressin Deficiency (central diabetes insipidus)

2023
EYRC Prizes @ 8th ENEA Workshop on Precision Pituitary Medicine, Munich – Germany, 7-9 December 2023
- BEST BASIC POSTER: Mirela Diana Ilie
Single-cell transcriptomics pinpoints placental growth factor and vascular endothelial growth factor (VEGF) receptor 1 as promising targets in gonadotroph tumors - BEST CLINICAL POSTER: Dario De Alcubierre
B-RAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: preliminary findings from a French multicenter study - BEST BASIC ORAL COMMUNICATION: Alexia Grasso
Unravelling the molecular mechanisms behind X-linked acrogigantisms: identification and validation of enhancers using biochemical and in vivo assays - BEST CLINICAL ORAL COMMUNICATION: Cihan Atila
Copeptin and oxytocin in MDMA-induced hyponatremia: a pooled analysis of four placebo-controlled cross-over trials
2022
EYRC Prizes @ 20th ENEA Congress, Lyon, France 7-10 September 2022
- BEST BASIC POSTER: Michel Pilot
Discrimination of pituitary neuroendocrine tumours by Raman spectroscopy - BEST CLINICAL POSTER: Mirela Diana Ilie
Efficacy and predictive factors of response to immunotherapy in pituitary carcinomas and aggressive pituitary tumors: a French cohort study - BEST CLINICAL POSTER: Sophie Monnerat
The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy - BEST BASIC ORAL COMMUNICATION: Fanny Chasseloup
Molecular mechanisms of cavernous sinus invasion by pituitary adenomas: in vitro studies and in vivo investigations in a rat model of invasive pituitary - BEST CLINICAL ORAL COMMUNICATION: Cihan Atila
New provocation test using MDMA (‘Ecstasy’) demonstrates Oxytocin deficiency in patients with central diabetes insipidus
2021
EYRC Prizes @ 7th ENEA Workshop on Cushing’s disease, (virtual), 10-11 December 2021
- BEST BASIC ORAL PRESENTATION AWARD – S. VETRIVEL ET AL.
Characterization of adrenal miRNA based dysregulations in Cushing‘s syndrome. - BEST CLINICAL ORAL PRESENTATION AWARD – M. MAZARI ET AL.
Determination of Cushing’s syndrome chronotype with the Munich chronotype questionnaire and actigraphy. - BEST BASIC POSTER AWARD – A. EBBEHOJ ET AL.
Cushing’s syndrome negatively affects socioeconomic variables many years prior to the diagnosis – a nationwide registry-based cohort study. - BEST CLINICAL POSTER AWARD – L. LIZZUL ET AL.
Cushing’s disease comorbidities after surgical remission vs. long-term medical treatment.
2021
EYRC Prizes @ 19th ENEA Congress, (virtual), 27-29 November 2020
- BEST BASIC POSTER: Julia Simon
Analysis of TP53 mutations in functional corticotroph tumours - BEST CLINICAL POSTER: Diana Borges Duarte
Biochemical control response rates with first generation somatostatin analogues in the real-life setting: the experience of a tertiary center - BEST BASIC ORAL COMMUNICATION: Giampaolo Trivellin
The X-linked acrogigantism-associated gene gpr101 regulates early embryonic development and growth in zebrafish - BEST CLINICAL ORAL COMMUNICATION: Daniela Salazar
Treatment of isolated idiopathic GH deficiency in children and thyroid function: is the need for levothyroxine a concern in long-term therapy?

